3 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Industries
Headquarters
Stage
Employees
Links
John A. Scarlett
View all
6 members
Columbia Care
2 followers
Travere Therapeutics
1 follower
Myovant Sciences
MeiraGTx
Cytokinetics
8 followers
Explore more companies